ATRX Alteration Contributes to Tumor Growth and Immune Escape in Pleomorphic Sarcomas

Archive ouverte

Darmusey, Lucie | Pérot, Gaëlle | Thébault, Noémie | Le Guellec, Sophie | Desplat, Nelly | Gaston, Laëtitia | Delespaul, Lucile | Lesluyes, Tom | Darbo, Elodie | Gomez-Brouchet, Anne | Richard, Elodie | Baud, Jessica | Leroy, Laura | Coindre, Jean-Michel | Blay, Jean-Yves | Chibon, Frédéric

Edité par CCSD ; MDPI -

International audience. Whole genome and transcriptome sequencing of a cohort of 67 leiomyosarcomas has been revealed ATRX to be one of the most frequently mutated genes in leiomyosarcomas after TP53 and RB1. While its function is well described in the alternative lengthening of telomeres mechanism, we wondered whether its alteration could have complementary effects on sarcoma oncogenesis. ATRX alteration is associated with the down-expression of genes linked to differentiation in leiomyosarcomas, and to immunity in an additional cohort of 60 poorly differentiated pleomorphic sarcomas. In vitro and in vivo models showed that ATRX down-expression increases tumor growth rate and immune escape by decreasing the immunity load of active mast cells in sarcoma tumors. These data indicate that an alternative to unsuccessful targeting of the adaptive immune system in sarcoma could target the innate system. This might lead to a better outcome for sarcoma patients in terms of ATRX status.

Suggestions

Du même auteur

Distinct Cellular Origins and Differentiation Process Account for Distinct Oncogenic and Clinical Behaviors of Leiomyosarcomas

Archive ouverte | Darbo, Elodie | CCSD

International audience. In leiomyosarcoma (LMS), a very aggressive disease, a relatively transcriptionally uniform subgroup of well-differentiated tumors has been described and is associated with poor survival. The ...

Medium levels of transcription and replication related chromosomal instability are associated with poor clinical outcome

Archive ouverte | Benhaddou, Ataaillah | CCSD

International audience. Genomic instability (GI) influences treatment efficacy and resistance, and an accurate measure of it is lacking. Current measures of GI are based on counts of specific structural variation (S...

Cell–cell fusion of mesenchymal cells with distinct differentiations triggers genomic and transcriptomic remodelling toward tumour aggressiveness

Archive ouverte | Delespaul, Lucile | CCSD

International audience. Cell-cell fusion is a physiological process that is hijacked during oncogenesis and promotes tumour evolution. The main known impact of cell fusion is to promote the formation of metastatic h...

Chargement des enrichissements...